Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
99 100 Next >
AINewsBreaks – Lantern Pharma (NASDAQ: LTRN) Reports Q2 2025 Results, Achieves Complete Responses in Multiple Trials, Expands AI Platform
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
Tickers LTRN
Exposures Artificial Intelligence Intellectual Property Product Safety
Clene Posts 70% Revenue Drop in Q2
Via The Motley Fool
Tickers CLNN
Exposures Product Safety
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 15, 2025 in Capricor Lawsuit - CAPR
Via NewMediaWire
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 22, 2025 in Replimune Group, Inc. Lawsuit - REPL
Via NewMediaWire
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
Retail Traders Pile Into Creative Medical After FDA Fast Tracks Degenerative Disc Disease Therapy
Via Stocktwits
Tickers CELZ
Exposures Product Safety
Levi &amp; Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 22, 2025 in Replimune Group, Inc. Lawsuit - REPL
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
Levi &amp; Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 15, 2025 in Capricor Lawsuit - CAPR
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Reports Q2 2025 Results, Advances Toward FDA Clearance and Commercial Launch
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
Tickers BEAT
Exposures Artificial Intelligence Intellectual Property Product Safety
Unicycive Posts 65% EPS Gain in Q2
Via The Motley Fool
Tickers UNCY
Exposures Product Safety
Brainstorm Posts 43% EPS Gain in Q2
Via The Motley Fool
Topics Intellectual Property
Tickers BCLI
Exposures Intellectual Property Product Safety
PharmaTher Founder and CEO Issues Letter to Shareholders Following the FDA Approval of Ketamine (KETARx(TM))
Via Newsfile
Tickers CSE:PHRM PHRRF
Exposures Product Safety
Hyperfine Q2 Revenue Jumps 26 Percent
Via The Motley Fool
Topics Artificial Intelligence
Tickers HYPR
Exposures Artificial Intelligence Product Safety
5 Revealing Analyst Questions From Natera’s Q2 Earnings Call
Via StockStory
Topics Earnings
Exposures Financial Product Safety
5 Insightful Analyst Questions From Hertz’s Q2 Earnings Call
Via StockStory
Topics Earnings Product Recall
Exposures Financial Legal Product Safety
5 Must-Read Analyst Questions From Artivion’s Q2 Earnings Call
Via StockStory
Topics Earnings
Exposures Financial Product Safety
5 Insightful Analyst Questions From Solventum’s Q2 Earnings Call
Via StockStory
Topics Earnings Product Recall
Tickers MMM
Exposures Financial Legal Product Safety
3 Reasons We’re Fans of DexCom (DXCM)
Via StockStory
Topics Stocks
Tickers DXCM
Exposures Product Safety US Equities
Allogene Q2 Cash Tops $300 Million
Via The Motley Fool
Tickers ALLO
Exposures Product Safety
The Book That Breaks the Silence: From Error to Error Exposes the Truth
Via Get News
Topics Product Recall
Exposures Legal Product Safety
Elvish Red Light Introduces FDA-Class II Medical-Grade LED Therapy Panels for Superior Wellness at Home
Via AB Newswire
Exposures Product Safety Regulatory
Hyperfine HYPR Q2 2025 Earnings Call Transcript
Via The Motley Fool
Topics Artificial Intelligence Earnings
Tickers HYPR
Exposures Artificial Intelligence Financial Product Safety
HeartBeam Cuts Costs Awaits FDA Decision
Via The Motley Fool
Tickers BEAT
Exposures Product Safety
HeartBeam (BEAT) Q2 2025 Earnings Call Transcript
Via The Motley Fool
Topics Artificial Intelligence Earnings
Tickers BEAT
Exposures Artificial Intelligence Financial Product Safety
Tenon Medical (TNON) Q2 2025 Earnings Transcript
Via The Motley Fool
Tickers TNON
Exposures Product Safety
IceCure Medical Advances FDA Review
Via The Motley Fool
Tickers ICCM
Exposures Product Safety
Hyperfine Inc (NASDAQ:HYPR) Reports Mixed Q2 2025 Earnings: Revenue Misses but Margins Improve
Via Chartmill
Tickers HYPR
Exposures Product Safety
HeartBeam Inc (NASDAQ:BEAT) Reports Q2 2025 Results: Narrower Loss, FDA Progress, and Mixed Market Reaction
Via Chartmill
Tickers BEAT
Exposures Product Safety
Spectral Ai Posts 32% Revenue Drop in Q2
Via The Motley Fool
Tickers MDAI
Exposures Product Safety
IceCure (ICCM) Q2 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Tickers ICCM
Exposures Financial Product Safety
Levi & Korsinsky Reminds Capricor Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 15, 2025 - CAPR
Via NewMediaWire
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.